Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02934191 · ClinicalTrials.gov registry record · Phase 2
Celecoxib After Tonsillectomy
A Phase 2 study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- Phase 2
- Development phase
- 172
- Enrollment target
NCT02934191 is a Phase 2 study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 172 participants.
The verdict
NCT02934191, a Phase 2 study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 172 participants
- Enrollment target
Study Summary
Tonsillectomy is one of the most common pediatric surgical procedures in the United States. Postoperative pain is substantial, with typical regimens employing narcotic derivatives and acetaminophen for 1-2 weeks after surgery. Recent enthusiasm for use of ibuprofen as an alternative has been tempered by equivocal data on its relative safety in regard to risk of postoperative hemorrhage. The primary objective is to evaluate efficacy of celecoxib for pain control after tonsillectomy in children. The secondary objective is to assess safety in regard to postoperative hemorrhage and adverse events.
Interventions
- DRUG Acetaminophen
- OTHER Placebo
- DRUG Celecoxib
- DRUG Oxycodone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2016-06 |
| Est. Completion | 2019-01-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02934191
The ClinicalTrials.gov registry entry for NCT02934191 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 172 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Acetaminophen is the first listed.
NCT02934191 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02934191 about?
NCT02934191 is a clinical study titled "Celecoxib After Tonsillectomy". Tonsillectomy is one of the most common pediatric surgical procedures in the United States. Postoperative pain is substantial, with typical regimens employing narcotic derivatives and acetaminophen for 1-2 weeks after surgery. Recent enthusiasm for use of ibuprofen as an alternative has been tempere...
What is the current status of trial NCT02934191?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 172 participants. The study started on 2016-06. Estimated completion is 2019-01-31.
What interventions are being tested in trial NCT02934191?
The interventions under investigation include: Acetaminophen (DRUG), Placebo (OTHER), Celecoxib (DRUG), Oxycodone (DRUG).
Who is sponsoring clinical trial NCT02934191?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.